Early bird closing soon! register now

Provide better postoperative pain outcomes for your patients with MAXIGESIC® IV (paracetamol 1000mg and ibuprofen (as sodium dihydrate) 300mg in 100mL, solution for infusion).

MAXIGESIC® IV provides effective combination analgesic therapy with the administration of a single formulation in postoperative patients unable to receive oral analgesics:

· Superior pain relief than paracetamol IV or ibuprofen IV alone

· Reduced opioid consumption compared with paracetamol IV and ibuprofen IV

· No compromise in safety compared with paracetamol IV and ibuprofen IV

· Simple opioid-free hospital-to-home transition

Share

Key dates

  • Abstract Submissions Open

    17 March 2025

  • Early Bird Registrations Open

    23 April 2025

  • Abstract Submissions Close

    1 July 2025 EXTENDED - 15 July 2025

  • Abstract Acceptance Notification

    Delayed - 29 August 2025

  • Volunteer Applications Close

    27 August 2025

  • Presenter Acceptance Deadline

    5 September 2025

  • Early Bird Registration Deadline

    8 September 2025

  • Presenter Registration Deadline

    23 September 2025

  • Standard Registration Deadline

    31 October 2025

More Partners / Exhibitors